AlphaMadera's AlphaVal page classifies Vertex, Inc. as a Platform & Compounding FCF business and values it using Two-stage FCF DCF, then compares the result to the current market price to flag VERX as undervalued, fairly valued, or overvalued.

What is Vertex, Inc.'s fair value?

Fair value for VERX comes from a Two-stage FCF DCF model -- the approach AlphaVal selected for this company's Platform & Compounding FCF classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value VERX?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. VERX was classified as Platform & Compounding FCF and is valued using Two-stage FCF DCF, built from VERX's most recent reported fundamentals.

VERX - Vertex, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $16.17 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong

Trading 75.9% above fair value

Current Price $13.77

Bear Case $4.81 65.1% downside ($4.81 - $13.77) / $13.77 = -65.1% 9% stage 1 growth, 11% discount

Fair Value $7.83 43.1% downside ($7.83 - $13.77) / $13.77 = -43.1% 16% stage 1 growth, 11% discount

Bull Case $11.24 18.4% downside ($11.24 - $13.77) / $13.77 = -18.4% 20% stage 1 growth, 11% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

15.5%

Discount Rate (WACC)

11.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (16% base case)

Terminal Value % of EV 43%

Implied Market Multiple 56.6x

Market is pricing in (growth) 22.8% vs our 15.5% base

Plain-Language Summary

Using a two-stage FCF DCF with 16% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $7.83 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (18 analysts) $16.17

Analyst Range $12.00 – $21.00

Divergence from AlphaVal 52%

Warnings

⚠ Stock-based employee pay equals 801% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.

ℹ Wall Street's average price target is $16.17 (from 18 analysts). Our estimate is 52% below the consensus -- consider that gap carefully.

⚠ This stock is 48% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions